HS
UTHR icon

Haafor (Singapore)’s United Therapeutics UTHR Stock Holding History

Haafor (Singapore)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,868
Closed -$290K – 232
2020
Q3 		$290K Buy
+2,868
New +$315K 0.6% 66
2020
Q1 		– Sell
-2,761
Closed -$243K – 359
2019
Q4 		$243K Buy
+2,761
New +$243K 0.16% 202

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Haafor (Singapore)'s UTHR Position: Q4 2020 in Review

Haafor (Singapore) sold out of United Therapeutics (UTHR) in Q4 2020, closing a stake of 2,868 shares — an estimated $290K sold.

Haafor (Singapore) first reported a position in UTHR in Q4 2019 and held it in 2 quarters. The position peaked at $290K in Q3 2020. 356 funds tracked by Wall St. Rank hold UTHR as of Q4 2020.

  • Haafor (Singapore) reported no remaining United Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Haafor (Singapore) sold 2,868 United Therapeutics shares in Q4 2020, an estimated $290K.
  • Haafor (Singapore) first reported a position in United Therapeutics in Q4 2019 and held it in 2 quarters.
  • Haafor (Singapore)'s United Therapeutics position peaked at $290K in Q3 2020.
  • 356 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2020.

Based on Haafor (Singapore)'s 13F filing for Q4 2020, filed 5 Feb 2021.